scholarly journals Fabricating Microporous Nano Silver Bacterial Cellulose Scaffolds Using a Laser‐cutting Instrument for Bone Tissue Regeneration

2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
Pelagie Favi ◽  
Sandra Alvarez ◽  
Ming Gao ◽  
Mukta Kachole ◽  
Thomas Webster
2020 ◽  
Vol 149 ◽  
pp. 51-59 ◽  
Author(s):  
Nichapa Klinthoopthamrong ◽  
Daneeya Chaikiawkeaw ◽  
Waranyoo Phoolcharoen ◽  
Kaewta Rattanapisit ◽  
Pornjira Kaewpungsup ◽  
...  

2019 ◽  
Vol 19 (4) ◽  
pp. 858
Author(s):  
Farah Nurlidar ◽  
Mime Kobayashi

Incorporation of bone-like hydroxyapatite into bacterial cellulose (BC) is an attractive approach for the fabrication of a bioactive three-dimensional (3D) scaffold for bone tissue regeneration. This study investigates the influence of the succinylation of BC on its ability to incorporate bone-like hydroxyapatite. A biomimetic process using a 1.5 × Simulated Body Fluid (SBF) was used to deposit the hydroxyapatite into the succinylated-BC. After soaking the succinylated-BC in the 1.5 × SBF for six days, Scanning Electron Microscope (SEM) images were taken and the composition of the succinylated-BC was analyzed by energy dispersive X-ray spectrometry. The biocompatibility of the scaffolds was tested in vitro using rat Bone Marrow Stromal Cells (rBMSCs). The SEM images and Fourier Transform Infrared Spectroscopy (FTIR) spectra showed that carbonated hydroxyapatite was deposited on the succinylated-BC. In contrast, only a small amount of carbonated hydroxyapatite deposition was observed on unmodified BC, indicating that the succinyl group in the BC is effective for inducing hydroxyapatite deposition. In vitro studies using rBMSCs revealed the biocompatibility of the scaffold. Combining with the ability of the cells to differentiate into bone cells, the succinylated-BC scaffold is a promising 3D scaffold for bone tissue regeneration.


2011 ◽  
Vol 02 (03) ◽  
pp. 239-243 ◽  
Author(s):  
G.M Olyveira ◽  
Daisy Pereira Valido ◽  
L.M.M. Costa ◽  
Plácia Barreto Prata Gois ◽  
Lauro Xavier Filho ◽  
...  

Author(s):  
Ahn Sung-Jun ◽  
Jeong Sung In ◽  
Jeong Jin-Oh ◽  
Park Jong-Seok ◽  
Gwon Hui-Jeong ◽  
...  

2020 ◽  
Vol 27 (6) ◽  
pp. 838-853 ◽  
Author(s):  
Madalina Icriverzi ◽  
Valentina Dinca ◽  
Magdalena Moisei ◽  
Robert W. Evans ◽  
Mihaela Trif ◽  
...  

: Among the multiple properties exhibited by lactoferrin (Lf), its involvement in bone regeneration processes is of great interest at the present time. A series of in vitro and in vivo studies have revealed the ability of Lf to promote survival, proliferation and differentiation of osteoblast cells and to inhibit bone resorption mediated by osteoclasts. Although the mechanism underlying the action of Lf in bone cells is still not fully elucidated, it has been shown that its mode of action leading to the survival of osteoblasts is complemented by its mitogenic effect. Activation of several signalling pathways and gene expression, in an LRPdependent or independent manner, has been identified. Unlike the effects on osteoblasts, the action on osteoclasts is different, with Lf leading to a total arrest of osteoclastogenesis. : Due to the positive effect of Lf on osteoblasts, the potential use of Lf alone or in combination with different biologically active compounds in bone tissue regeneration and the treatment of bone diseases is of great interest. Since the bioavailability of Lf in vivo is poor, a nanotechnology- based strategy to improve the biological properties of Lf was developed. The investigated formulations include incorporation of Lf into collagen membranes, gelatin hydrogel, liposomes, loading onto nanofibers, porous microspheres, or coating onto silica/titan based implants. Lf has also been coupled with other biologically active compounds such as biomimetic hydroxyapatite, in order to improve the efficacy of biomaterials used in the regulation of bone homeostasis. : This review aims to provide an up-to-date review of research on the involvement of Lf in bone growth and healing and on its use as a potential therapeutic factor in bone tissue regeneration.


Author(s):  
Bipin Gaihre ◽  
Xifeng Liu ◽  
Linli Li ◽  
A. Lee Miller ◽  
Emily T. Camilleri ◽  
...  

Nanomaterials ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1611
Author(s):  
Caroline J. Harrison ◽  
Paul V. Hatton ◽  
Piergiorgio Gentile ◽  
Cheryl A. Miller

Injectable nanoscale hydroxyapatite (nHA) systems are highly promising biomaterials to address clinical needs in bone tissue regeneration, due to their excellent biocompatibility, bioinspired nature, and ability to be delivered in a minimally invasive manner. Bulk strontium-substituted hydroxyapatite (SrHA) is reported to encourage bone tissue growth by stimulating bone deposition and reducing bone resorption, but there are no detailed reports describing the preparation of a systematic substitution up to 100% at the nanoscale. The aim of this work was therefore to fabricate systematic series (0–100 atomic% Sr) of SrHA pastes and gels using two different rapid-mixing methodological approaches, wet precipitation and sol-gel. The full range of nanoscale SrHA materials were successfully prepared using both methods, with a measured substitution very close to the calculated amounts. As anticipated, the SrHA samples showed increased radiopacity, a beneficial property to aid in vivo or clinical monitoring of the material in situ over time. For indirect methods, the greatest cell viabilities were observed for the 100% substituted SrHA paste and gel, while direct viability results were most likely influenced by material disaggregation in the tissue culture media. It was concluded that nanoscale SrHAs were superior biomaterials for applications in bone surgery, due to increased radiopacity and improved biocompatibility.


Sign in / Sign up

Export Citation Format

Share Document